Specify Company / Ticker to Get the Summary
Dividend History ARMP
Dividend Analytics ARMP
Max Ratio
–5Y Dividend Growth
–Consecutive Years
–5Y Average Payout Ratio
–Armata Pharmaceuticals Inc
ARMPArmata Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company that focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections worldwide. It develops its products using its proprietary bacteriophage-based technology. The company's product candidates include AP-SA02 for the treatment of Staphylococcus aureus bacteremia; AP-PA02 for Pseudomonas aeruginosa; and AP-PA03 for the treatment of pneumonia. It has research collaboration agreement with Merck Sharp & Dohme Corp. for developing synthetic bacteriophage candidates to target undisclosed infectious disease agents. The company is based in Los Angeles, California. Armata Pharmaceuticals, Inc. operates as a subsidiary of Innoviva, Inc. Address: 5005 McConnell Avenue, Los Angeles, CA, United States, 90066
Analytics
WallStreet Target Price
9.00 USDP/E Ratio
–Dividend Yield
–Financials ARMP
Results | 2019 | Dynamics |